Esperion Therapeutics Inc. (ESPR) has entered into a new financial arrangement with the Athyrium Fund.
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
According to the terms of the agreement, the Athyrium Fund will have the right to receive tiered royalties based on Esperion's net sales, with rates ranging from 12% to 33%. In addition, the Athyrium Fund will also be eligible for a series of milestone payments. These financial benefits will continue to accrue until the Athyrium Fund achieves a total return equal to 2.0 times its initial investment.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
JPMorgan Chase: SpaceX Inclusion in Nasdaq 100 Index Could Trigger $4.3 Billion Passive Fund Inflows
BlockBeats•2026/06/27 09:54
Exchange leads you to trending coins: AAVE's popularity rises, up 11.53% in 24H
AiCoin•2026/06/27 09:33
NAVI Protocol incubates Premium Exchange ecosystem token PST, which will soon be launched
Chaincatcher•2026/06/27 09:16
Trending news
MoreCrypto prices
MoreBitcoin
BTC
$60,307.76
+1.02%
Ethereum
ETH
$1,579.4
+1.69%
Tether USDt
USDT
$0.9985
-0.01%
USDC
USDC
$0.9997
+0.01%
XRP
XRP
$1.06
+2.51%
Solana
SOL
$71.67
+3.93%
TRON
TRX
$0.3205
-0.47%
Hyperliquid
HYPE
$62.76
-0.01%
Dogecoin
DOGE
$0.07522
+1.74%
Zcash
ZEC
$407.23
+1.61%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now